3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
3
CNS
1
Conditions
Stroke
1
Hemianopsia
1
Brain Neoplasms
1
Brain Injuries, Traumatic
1
Blindness, Cortical
1
Interventions
Temozolomide
78
Magnetic Resonance Spectroscopy
69
Specimen Handling
45
Radiotherapy
42
Bevacizumab
28
Radiosurgery
27
Cyclophosphamide
27
pembrolizumab
20
Radiation
20
Blood Specimen Collection
19
fludarabine
16
Nivolumab
16
Irinotecan
14
Carboplatin
13
Biopsy
13
Etoposide
12
Vincristine
11
Pemetrexed
11
Lomustine
11
Surgical Procedures, Operative
9
trametinib
8
dinutuximab
8
abemaciclib
8
Ipilimumab
8
Fluorodeoxyglucose F18
8
naxitamab
7
fluciclovine F-18
7
Watchful Waiting
7
Topotecan
7
Proton Therapy
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Transcranial Direct Current Stimulation
×
CNS
×
Clear all
NCT07105358
2025-08-05
VIBRANT
Georgetown University
Phase NA
Recruiting
30 enrolled